Evidence map›Paper›PMID 30962701›Full record

ArticleClinical, cosmetic and investigational dermatology2019

A series of in vitro and human studies of a novel lip cream formulation for protecting against environmental triggers of recurrent herpes labialis.

Christoph F Gfeller, Rita Wanser, Harish Mahalingam, David J Moore, Xuying Wang, Connie B Lin, Gilbert Shanga, Gary Grove, Anthony V Rawlings

Open access · goldAbstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Clinical Features and Biophysical Characteristics of Lips of South Asian Women.Clinical, cosmetic and investigational dermatology · 2023
    Article
  6. Article
  7. [Herpes simplex factors: Literature review].Revista cientifica odontologica (Universidad Cientifica del Sur)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Christoph F GfellerGlaxoSmithKline Consumer Healthcare, Medical Affairs Skin Health, Weybridge, Surrey, UK.
Rita WanserGlaxoSmithKline Consumer Healthcare, Medical Affairs Skin Health, Warren, NJ, USA, harish.x.mahalingam@gsk.com.
Harish MahalingamGlaxoSmithKline Consumer Healthcare, Medical Affairs Skin Health, Warren, NJ, USA, harish.x.mahalingam@gsk.com.
David J MooreGlaxoSmithKline Consumer Healthcare, R&D Innovation Skin Health, Weybridge, Surrey, UK.
Xuying WangGlaxoSmithKline Consumer Healthcare, R&D Innovation Skin Health, Collegeville, PA, USA.
Connie B LinGlaxoSmithKline Consumer Healthcare, R&D Innovation Skin Health, Collegeville, PA, USA.
Gilbert ShangaGSK Consumer Healthcare, Biostatistics, Warren, NJ, USA.
Gary GrovecyberDERM, Inc., Broomall, PA, USA.
Anthony V RawlingsAVR Consulting, Ltd., Cheshire, UK.
GlaxoSmithKline (India) · INGlaxoSmithKline (United Kingdom) · GBGlaxoSmithKline (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThese studies describe the testing of a novel, daily-use lip cream designed for individuals with lips prone to recurrent herpes labialis (RHL) that protects against environmental triggers. SUBJECTS AND

methodsIn vitro occlusive and in vitro and in vivo photoprotection analyses, a characterization of normal vs dry lips, and a randomized, evaluator-blinded, clinical trial that assessed the lip cream in healthy subjects with dry lips were conducted. In the clinical trial, subjects applied the lip cream or were untreated and evaluated using transepidermal water loss (TEWL), corneometry, visual assessments of lip dryness, expert photographic evaluations, and subject-rated outcomes.

resultsThe lip cream's in vitro water vapor transmission rate (84.1 g/(m

conclusionThese studies indicate that this novel, daily-use lip cream protects against UV radiation, drying, and chapping, which are established environmental RHL triggers.

Indexed as

barrier functionherpes simplex viruslip careUV radiation

Identifiers

PMID30962701
PMCPMC6432897
OpenAlexW2924749644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.